Evaluation of clinical outcome and predictive factors for thromboembolism or hemorrhagic complications in patients treated for chronic subdural hematoma. A prospective observational study

The impact of anticoagulant and antiplatelet medications on clinical outcome and risk of complications is uncertain in chronic subdural hematoma (CSDH) patients. Currently, evidence-based guidelines and specific neurosurgical scores lacks. CHA₂DS₂-VASc and HAS-BLED scores have been proven to help predicting complications in the perioperative period of non-cardiac surgeries. We performed a multicenter prospective observational trial to evaluate the clinical outcomes and complications of CSDH patient undergoing surgery, comparing patients taking anticoagulant/antiplatelet (AAPT) and not (NT). Additionally, we investigated the role of CHA₂DS₂-VASc and HAS-BLED scores in predicting thromboembolic events or hemorrhages. No associations have been found between AAPT and clinical outcomes of patients. Emergency surgery was not a significant factor in improving outcomes. Post-operative hemorrhages were more frequent in the AAPT group, but none required a second surgery. A significant higher risk of of new bleedings was found in the ASA group with discontinuation ≤ 5 days. A higher HAS-BLED score was not associated with a worse clinical outcome. A 1-point increase in CHA₂DS₂-VASc was associated with a lower probability of favorable outcomes at 1 month. 90% of AAPT and 44% of NT patients were at moderate-high risk of thromboembolic events based on CHA₂DS₂-VASc score, with no difference in incidence between groups. The use of AAPT does not influence outcomes, complication rates, or recurrence in patients undergoing surgery for CSDH. Scores such as CHA₂DS₂-VASc or HAS-BLED could aid in stratifying bleeding and thromboembolic risks and in the management of these drugs in the perioperative period.

Authors

Institutions

Publication Details

Journal
Neurosurgical Review
Published
2025-03-17
DOI
https://doi.org/10.1007/s10143-025-03441-0
Citations
1
Primary Topic
Neurosurgical Procedures and Complications
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of clinical outcome and predictive factors for thromboembolism or hemorrhagic complications in patients treated for chronic subdural hematoma. A prospective observational study

Tamara Ius, Mariachiara Sensi, Carmelo Lucio Sturiale, Alberto Benato et al.
1 citations
Neurosurgical Review
Neurosurgical Procedures and Complications
1.39
article

Evaluation of clinical outcome and predictive factors for thromboembolism or hemorrhagic complications in patients treated for chronic subdural hematoma. A prospective observational study

Tamara Ius, Mariachiara Sensi, Carmelo Lucio Sturiale, Alberto Benato, Pietro Zangrossi, Pasquale De Bonis, Donato Carlo Zotta, Gianluca Trevisi, Daniele Piccolo, Rosario Maugeri, Antonino Raco, Fabio Raneri, Oriela Rustemi, Samantha Eichner, Giovanni Pennisi, Giorgio Lofrese, G. Mantovani, Antonella Mangraviti, Francesco Signorelli, Luca Ricciardi, Michele Alessandro Cavallo, Maria Elena Flacco, Nicola Montemurro, Alba Scerrati, Lorenzo Mongardi, Paul Roblot
article en
1 citations

Abstract

The impact of anticoagulant and antiplatelet medications on clinical outcome and risk of complications is uncertain in chronic subdural hematoma (CSDH) patients. Currently, evidence-based guidelines and specific neurosurgical scores lacks. CHA₂DS₂-VASc and HAS-BLED scores have been proven to help predicting complications in the perioperative period of non-cardiac surgeries. We performed a multicenter prospective observational trial to evaluate the clinical outcomes and complications of CSDH patient undergoing surgery, comparing patients taking anticoagulant/antiplatelet (AAPT) and not (NT). Additionally, we investigated the role of CHA₂DS₂-VASc and HAS-BLED scores in predicting thromboembolic events or hemorrhages. No associations have been found between AAPT and clinical outcomes of patients. Emergency surgery was not a significant factor in improving outcomes. Post-operative hemorrhages were more frequent in the AAPT group, but none required a second surgery. A significant higher risk of of new bleedings was found in the ASA group with discontinuation ≤ 5 days. A higher HAS-BLED score was not associated with a worse clinical outcome. A 1-point increase in CHA₂DS₂-VASc was associated with a lower probability of favorable outcomes at 1 month. 90% of AAPT and 44% of NT patients were at moderate-high risk of thromboembolic events based on CHA₂DS₂-VASc score, with no difference in incidence between groups. The use of AAPT does not influence outcomes, complication rates, or recurrence in patients undergoing surgery for CSDH. Scores such as CHA₂DS₂-VASc or HAS-BLED could aid in stratifying bleeding and thromboembolic risks and in the management of these drugs in the perioperative period.

Neurosurgical ReviewVol. 48(1)
Università Cattolica del Sacro Cuore (IT), University of Pisa (IT), University of Ferrara (IT), Agostino Gemelli University Polyclinic (IT), Centre Hospitalier Universitaire de Bordeaux (FR), Ospedale di Santo Spirito (IT), Hôpital Pellegrin (FR), Ospedale “M. Bufalini” di Cesena (IT), Ospedale Santa Maria della Misericordia di Udine (IT), Azienda Ospedaliera Universitaria Pisana (IT), Sapienza University of Rome (IT), University of Palermo (IT)
Università Cattolica del Sacro Cuore
Good health and well-being
Openalex Percentile: Top 22%
Neurosurgical Procedures and Complications
1.39
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.